Journal: Molecular Imaging and Biology

Molecular Imaging and Biology presents original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health.

The objective of MIB is to provide a forum for the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures.

Molecular Imaging and Biology is the official journal of the World Molecular Imaging Society (WMIS), the European Society for Molecular Imaging (ESMI), and the Federation of Asian Societies for Molecular Imaging (FASMI).

Online Access to Molecular Imaging and Biology

Members of WMIS may access their free online subscription to Molecular Imaging and Biology by logging in to their member profile page here.

Use the email address associated with your membership. There is an option to reset your password. After logging in look for the link to the journal on your profile home page.

2022 Papers of the Year

“FDG PET/CT and Dosimetric Studies of Lu-Lilotamab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma – Are We Hitting the Target?”

by Ayca Løndalen, Johan Blakkisrud, Mona-Elisabeth Revheim, Jostein Dahle, Arne Kolstad, and Caroline Stokke.

“I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection”

by Camilo A. Ruiz-Bedoya, Filipa Mota, Alvaro A. Ordonez, Catherine A. Foss, Alok K. Singh, Monali Praharaj, Farina J. Mahmud, Ali Ghayoor, Kelly Flavahan, Patricia De Jesus, Melissa Bahr, Santosh Dhakal, Ruifeng Zhou, Clarisse V. Solis, Kathleen R. Mulka, William R. Bishai, Andrew Pekosz, Joseph L. Mankowski, Jason Villano, Sabra L. Klein, and Sanjay K. Jain.

“Incremental Impact of [68 Ga]Ga‑PSMA‑11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative‑Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI”

by Florian Szigeti, Gregor Schweighofer-Zwink, Matthias Meissnitzer, Cornelia Hausner-Kronberger, Wolfgang Hitzl, Thomas Kunit, Rosemarie Fostner, Christian Pirich, and Mohsen Beheshti.